|

Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding

RECRUITINGSponsored by Mayo Clinic
Actively Recruiting
SponsorMayo Clinic
Started2024-03-27
Est. completion2027-06-30
Eligibility
Age55 Years+
SexFEMALE
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →

NCT06365905

Summary

This study evaluates if AI can be used with transvaginal ultrasound images for early detection of endometrial cancer or premalignant lesions.

Eligibility

Age: 55 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Age ≥ 55 years
* At least one episode of postmenopausal bleeding (PMB)
* Endometrial biopsy available from at Mayo Clinic (MN, AZ, FL), Mayo Clinic Health System (MCHS), or an external institution
* Acceptance to participate in the study

Exclusion Criteria:

* Diagnostic tests performed more than 90 days apart
* Physical impediment/refusal to undergo transvaginal ultrasound (TVUS)

Conditions2

CancerEndometrial Carcinoma

Locations3 sites

Arizona

1 site
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259
Clinical Trials Referral Office855-776-0015mayocliniccancerstudies@mayo.edu

Florida

1 site
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980
Clinical Trials Referral Office855-776-0015mayocliniccancerstudies@mayo.edu

Minnesota

1 site
Mayo Clinic in Rochester
Rochester, Minnesota, 55905
Clinical Trials Referral Office855-776-0015mayocliniccancerstudies@mayo.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.